OraSure Technologies Inc (OSUR)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

150 WEBSTER ST BETHLEHEM, PA 18015

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure's portfolio of products is sold globally to clinical laboratories, hospitals, physician's offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers.

Data as of 2021-10-09 09:07:04 -0400
Market Cap805.06 Million Shares Outstanding72.009 Million Avg 30-day Volume1.092 Million
P/E Ratio151.61205 Dividend Yield0.0 EPS0.074
Price/Sales3.39 Debt to Equity1.15 EBITDA32.553 Million
Price to Book Value1.9 Forward PE236.9 Enterprise Value579.777 Million
Total Cash193.305 Million Current Debt46.572 Million Gross Profit137.472 Million
BETA-0.0918 52-week High/Low17.79 / 8.58 Next Earnings Date2021-11-03 Price to Cash FLow (P/CF) -606.8979
Data provided by IEX Cloud
View SEC Filings from OSUR instead.

View recent insider trading info

Funds Holding OSUR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OSUR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DATIN JAMES A DIRECTOR

27,671 2021-09-30 6

GLEASON SCOTT CFO

20,439 2021-09-17 1

LANCASTER RONNY B DIRECTOR

34,782 2021-05-18 1

MARMORA LELIO DIRECTOR

17,967 2021-05-18 1

HOBBS EAMONN P DIRECTOR

43,861 2021-05-17 1

CELANO MICHAEL DIRECTOR

78,460 2021-05-17 1

ASPINALL MARA G. DIRECTOR

35,937 2021-05-17 1

SHULKIN DAVID DIRECTOR

24,846 2021-05-17 1

NIBAUER LISA EVP & BU LEAD-DIAGNOSTICS

32,234 2021-05-11 2

CUCA ROBERTO CFO

114,815 2021-05-07 2

JERRETT JACK E SVP GENERAL COUNSEL & CCO

144,875 2021-02-01 1

TANG STEPHEN S PHD PRESIDENT AND CEO

260,201 2021-02-01 1

WEBER KATHLEEN GALLAGHER EVP & BU LEAD - MOLECULAR

113,634 2021-02-01 2

MILLER MICHELE MARIE VP, FINANCE AND CONTROLLER

16,884 2021-02-01 1

PATRICK CHARLES W DIRECTOR

58,446 2020-05-15 0

ZEZZO II ANTHONY EVP & BU LEAD - INFECTIOUS

227,867 2020-02-01 0

SARIN ARADHANA DIRECTOR

16,865 2019-05-21 0

REED MICHAEL SVP R&D AND CSO

49,217 2019-04-18 0

KUNA MARK L SEE REMARKS

  • Officer
No longer subject to file 2018-10-22 0

SPAIR RONALD H COO & CFO

  • Officer
  • Director
No longer subject to file 2018-06-08 0

MICHELS DOUGLAS A PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2018-03-31 0

SMITH BRIAN EVP & BU LEAD - MOLECULAR

  • Officer
18,075 2018-02-15 0

PRINGLE ROGER L

  • Director
No longer subject to file 2017-05-15 0

WATSON DOUGLAS G

  • Director
No longer subject to file 2016-11-13 0

WHITTERS ERIC SVP, RESEARCH AND DEVELOPMENT

  • Officer
9,857 2015-02-03 0

OSTROV GERALD M

  • Director
39,346 2014-05-22 0

LEE STEPHEN R EXEC. VP & CSO

  • Officer
55,815 2014-02-01 0

GOLDSTEIN JACK

  • Director
36,000 2011-02-01 0

MENDEZ MANUEL O. VP MARKETING & SALES

  • Officer
13,930 2010-01-27 0

FORMICA P MICHAEL EXEC. VP & GM CRYO. SYS. DIV.

  • Officer
147,874 2009-08-19 0

ZACK JOSEPH E EXEC. VP - MKTG. & SALES

  • Officer
58,050 2008-01-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DATIN JAMES A DIRECTOR

2021-10-01 16:25:02 -0400 2021-09-30 A 1,404 $11.58 a 27,671 direct 0.3721 1.3023 5.0233 4 -0.2791 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 22:15:04 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 21:45:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 21:15:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 20:45:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 20:15:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 19:45:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 19:15:04 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 18:45:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 18:15:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 17:45:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 17:15:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 16:45:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 16:15:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 15:45:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 15:15:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 14:45:02 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 14:15:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 13:45:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 13:15:03 UTC -0.18 0.25 3200000
ORASURE TECHNOLOGIES INC OSUR 2021-10-15 12:45:03 UTC -0.18 0.25 3200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund OSUR -123.0 shares, $-1323.48 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund OSUR -5.0 shares, $-53.8 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund OSUR -76.0 shares, $-817.76 2020-03-31 N-PORT

Elevate your investments